Example: Heart Attack

Search clinical trials for: Complement Factor I

Total 44 results

NCT01834989

Active, not recruiting

Patellar Tendinopathy - Effect of Training and Enhancement of the Collagen Synthesis by Insulin-like Growth Factor-I

Conditions: Tendinopathy
NCT00004419

Completed

Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance

Conditions: Insulin Resistance; Hyperglycemia
NCT00004699

Completed

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Conditions: Hyperinsulinism
NCT00004700

Completed

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Conditions: Hyperinsulinism
NCT00004825

Completed

Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

Conditions: Hyperinsulinism
NCT01823822

Completed

Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa

Conditions: Anorexia Nervosa
NCT00969644

Unknown status

The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons

Conditions: Interaction Between the GH/IGF-I System and the Immune-system
NCT00577577

Unknown status

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Conditions: Myotonic Dystrophy Type 1
NCT00915954

Completed

Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)

Conditions: Acromegaly; Type 2 Diabetes Mellitus
NCT00005105

Unknown status

Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation

Conditions: Intrauterine Growth Retardation
NCT01365962

Completed

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

Conditions: Sarcoma
NCT02084095

Completed

IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly

Conditions: Acromegaly
NCT01182883

Withdrawn

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

Conditions: Brain Stem Neoplasms; Glioma; Pinealoma
NCT00880282

Completed

Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment

Conditions: Unspecified Childhood Solid Tumor, Protocol Specific
NCT00785538

Completed

A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatment or For Whom No Treatment is Available

Conditions: Advanced Solid Tumors
NCT00517062

Completed

Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates

Conditions: Growth Hormone Deficiency
NCT00785941

Completed

A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Conditions: Advanced Solid Tumors
NCT01340040

Completed

Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects

Conditions: Cancer; Advanced Solid Malignancies
NCT00001878

Completed

Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts

Conditions: Hypertrophic Cardiomyopathy; Left Ventricular Hypertrophy
NCT00845039

Terminated

A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab

Conditions: Colon Cancer; Rectal Cancer
NCT00816361

Completed

A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors

Conditions: Cancer
NCT02427217

Completed

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

Conditions: Congenital Fibrinogen Deficiency
NCT01565239

Completed

Fiix-prothrombin Time for Monitoring Warfarin

Conditions: Thromboembolism; Arterial; Venous
NCT04349839

Recruiting

ACRODAT Prospective Evaluation Study

Conditions: Acromegaly
NCT01811576

Completed

Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Conditions: Growth Hormone Deficiency